To some extent, the non-apoptotic and pro-necroptotic effect of TQ could be beneficial against CHOP-resistant DLBCL, but this notion requires further validation with a greater number of primary samples and in vivo experiments. The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.